Global  

Celebrating 10 Years of Trusted News Discovery
One News Page
> >

PreveCeutical Medical unveils promising findings from non-addictive analgesics program

Proactive Investors Tuesday, 8 January 2019
Health sciences group PreveCeutical Medical Inc (CSE:PREV) (OTCMKTS:PRVCF) said it had completed a study of peptides to develop as non-addictive painkillers, with promising results. The firm is developing therapies using organic and nature identical products. READ: PreveCeutical Medical reports converting acid phytocannabinoids to neutral form One of its programs is for non-addictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone. Preveceutical said that via a meticulous process it had now identified five novel peptide constructs, which preferentially target the receptor subtype which is of interest to the company and is purported to avoid addictive and tolerance-inducing side effects. This subset of peptides has demonstrated potency, in a well-accepted functional dose response assay, that is on par with clinically available agents, such as morphine, the company added. Chief research officer Dr Harendra Parekh told investors: "We are very pleased with this promising development, as a result of numerous iterations between our peptide design and cell-based screening efforts, we have now yielded a number of constructs which discriminate between the key pain receptors in the body, and importantly, avoid activation of those purported to lead to dependence." Preveceutical shares in Toronto were unchanged at $0.06 each. Contact Giles at giles@proactiveinvestors.com Follow him on Twitter @Gile74
0
shares
ShareTweetSavePostSend
 

Recent related news from verified sources

PreveCeutical Medical closes C$305,000 non-brokered private placement financing

PreveCeutical Medical Inc (OTCMKTS:PRVCF) (CSE:PREV) announced Tuesday the closing of a C$305,000 non-brokered private placement financing. The health-sciences...
Proactive Investors

PreveCeutical Announces Appointment of Dr. Makarand Jawadekar as President

DGAP-News: PreveCeutical Medical Inc. / Key word(s): Miscellaneous 13.02.2019 / 14:31 The issuer is solely responsible for the content of this...
EQS Group

You Might Like


Tweets about this


Other recent news in Business

The credit of British companies is declining in quality and austerity and BREXIT are largely to blameOLIVES PITTING US AGAINST EU IN GLOBAL TRADE FIGHT
Alexandria Ocasio-Cortez's Green New Deal is right about transforming transportation — but we don't have to wait for its more ambitious goalsPURPLEBRICKS SHARES DIVE ON SALES OUTLOOK SHOCK
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest